Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Morgan Stanley initiates coverage of Ovintiv with an "equal weight" rating and $68 price target.
Morgan Stanley initiated coverage of Ovintiv with an "equal weight" rating and an $68.00 price target, predicting nearly 9% upside.
Other analysts are bullish, with Goldman Sachs upgrading to a "buy" and Royal Bank of Canada maintaining an "outperform" rating.
Ovintiv recently reported strong earnings beating expectations, though insiders have sold shares.
3 Articles
Morgan Stanley inicia la cobertura de Ovintiv con una calificación de "peso igual" y un precio objetivo de $68.